The trademark GINALIA was filed by PHARMAPHENIX, S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant") and AP 21 Pharm s.c.c.l., a corporation established under the laws of the Kingdom of Spain (the "Co-Applicant", and jointly with the "Applicant" referred to as the "Applicants" going forward). The application was published for oppositions on March 13, 2022, and received one opposition filed on May 18, 2022 by EPITECH GROUP S.p.A. on Likelihood of confusion. the opponent was represented by NOTARBARTOLO & GERVASI S.P.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 18, 2022
The application was filed in Spanish, and Spanish was also language of all opposition proceedings (English was selected as the second language).